Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Lidan Geng"'
Publikováno v:
BMC Neurology, Vol 22, Iss 1, Pp 1-5 (2022)
Abstract Background Patients with bone metastasis often experience severe pain that is difficult to control and seriously affects quality of life. Radiotherapy is an effective way to relieve pain in these patients. Currently, there is no standard rec
Externí odkaz:
https://doaj.org/article/23fa3f27cd854dc99391c2be551f703d
Autor:
Rong Wu, Lidan Geng, Zhenhua Zhao, Dongbiao Liao, Bin He, He Hu, Yanqun Lin, Musheng Li, Miao Xiang, Yu Zhang, Gang Feng, Bangxian Tan, Xiaobo Du
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: This study aimed to investigate the specificity and sensitivity of oral meglumine diatrizoate esophagogram in screening for esophageal fistula during radiotherapy or chemoradiotherapy for esophageal cancer and determine if early detection
Externí odkaz:
https://doaj.org/article/1b91f9ddb24f4290b2b9c56c59b793b9
Autor:
Huan Du, Gang Feng, Yu Zhang, Surong Ren, Xiyue Yang, Lidan Geng, Jie Li, Binwei Lin, Li Yuan, Yixue Wen, Miao Xiang, Xiaobo Du
Publikováno v:
The Oncologist
Lessons Learned Background This study aimed to evaluate the efficacy and safety of anlotinib combined with S-1 as a third- or later-line treatment for patients with stage IV non-small cell lung cancer (NSCLC). Anlotinib was approved in 2018 by the Ch
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0df4f92eaef791306392dd33a1bd8ea7
https://doi.org/10.1002/onco.13950
https://doi.org/10.1002/onco.13950
Publikováno v:
BMC neurology. 22(1)
Background Patients with bone metastasis often experience severe pain that is difficult to control and seriously affects quality of life. Radiotherapy is an effective way to relieve pain in these patients. Currently, there is no standard recommended
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1032a92d13556cf9ea7296bfea698537
https://pubmed.ncbi.nlm.nih.gov/35725414
https://pubmed.ncbi.nlm.nih.gov/35725414
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background A proportion of patients with stage IV non-small-cell lung cancer (NSCLC) is predicted to receive third-line treatment. However, currently no standard third-line treatment for NSCLC is available. Anlotinib is an oral, multi-targeted tyrosi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2961943e96cb4186775ea31c96b836e7
https://doi.org/10.31557/apjcp.2019.20.12.3849
https://doi.org/10.31557/apjcp.2019.20.12.3849
Autor:
Gang Feng, Lidan Geng, Xiaobo Du, Tangzhi Dai, Huan Du, Xiyue Yang, Zhongzheng Xiang, Lei Liu, Jie Li, Yixue Wen, Yu Zhang, Jie Bai
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 154
BACKGROUND AND PURPOSE This study aimed to evaluate the efficacy of radical radiotherapy and assess prognostic factors in metachronous oligometastatic esophageal cancer (MOEC) patients after initial treatment with curative-intent surgery and/or chemo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccaadef1946d4d9786de9c1b7c310b6d
https://pubmed.ncbi.nlm.nih.gov/32980382
https://pubmed.ncbi.nlm.nih.gov/32980382
Autor:
Guobo Du, Lei Liu, Hongwei Cai, Tangzhi Dai, Yu Zhang, Zhenhua Zhao, Gang Feng, Xiaobo Du, Dongbiao Liao, Xuhai Zhen, Yixue Wen, Jie Bai, Jie Li, Lidan Geng, Miao Xiang, Xiyue Yang
Publikováno v:
Medicine
Introduction: Re-irradiation after radiotherapy is a common treatment for locally recurrent esophageal cancer. However, the side effects of re-irradiation are serious. The most serious adverse reactions of re-irradiation include esophageal perforatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5fe24f35e02e6141c8c4574e820145e
https://pubmed.ncbi.nlm.nih.gov/31261551
https://pubmed.ncbi.nlm.nih.gov/31261551
Autor:
MIAO XIANG, XIYUE YANG, SURONG REN, HUAN DU, LIDAN GENG, LI YUAN, YIXUE WEN, BINWEI LIN, JIE LI, YU ZHANG, GANG FENG, XIAOBO DU
Publikováno v:
Oncologist; Dec2021, Vol. 26 Issue 12, pe2130-e2135, 6p, 1 Chart, 2 Graphs
Publikováno v:
Medicine
To date, no effective biological markers have been identified for predicting the prognosis of esophageal cancer patients. Recent studies have shown that eosinophils are independent prognostic factors in some cancers. This study aimed to identify the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::274a105ced31aa22895e531c5a09ba60
https://doi.org/10.1097/md.0000000000024328
https://doi.org/10.1097/md.0000000000024328
Publikováno v:
Medicine; 1/22/2021, Vol. 100 Issue 3, p1-7, 7p